COMT methylation as a potential peripheral biomarker of schizophrenia
Schizophrenia is a common debilitating neuropsychiatry disorder. Currently, absolute clinical criteria (DSM-V) are used for the diagnosis. Identification of prediction and therapeutic markers of schizophrenia could expedite the disease diagnosis and management. Catechol-O-methyltransferase (COMT) wh...
Main Authors: | Abd. Rahim, Nour El Huda, Rahim Mohd, Nabil Fikri, Mohd Noor, Hanisah, Abdullah, Kartini, Ku Zaifah, Norsidah, A. Talib, Norlelawati |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/57642/ http://irep.iium.edu.my/57642/13/57642.pdf |
Similar Items
-
Two-year outcomes of quality of life among heroin dependants at Methadone Maintenance Therapy (MMT) clinic
by: Musa, Ramli
Published: (2015) -
Effect of Nigella sativa on chronic cerebral hypoperfusion-induced memory and learning impairment
by: Azzubaidi, Marwan Saad, et al.
Published: (2012) -
Prediction of clinical symptoms of schizophrenia based on COMT methylation marker
by: Abd. Rahim, Nour El Huda, et al.
Published: (2017) -
Epigenetic changes of DRD2 gene in pathogenesis of schizophrenia
by: Abd. Rahim, Nour El Huda, et al.
Published: (2017) -
Relationship of brain derived neurotrophic factor DNA methylation with psychopathologic symptoms and antipsychotics in stable schizophrenia
by: Abd. Rahim, Nour El Huda, et al.
Published: (2016)